The Mixed Lineage Leukemia (MLL) gene is involved in lymphoblastic and myeloid leukemia through chromosome translocations leading to fusion of MLL to partner genes, or through internal MLL rearrangements. MLL is the mammalian counterpart of the Drosophila trithorax (trx) gene, involved in maintaining active gene expression states. We have used transgenic Drosophila to assess the molecular targets and cellular processes affected by MLL and two of its leukemic fusion proteins. We find that whereas expression of normal human MLL in flies does not result in phenotypic alterations, overexpressing the human MLL-AF9 and MLL-AF4 proteins causes larval to pupal lethality, which interestingly resembles the phenotypes displayed by certain Drosophila trx mutant alleles. MLL-AF9 and MLL-AF4 transgenic flies exhibit antagonistic alterations in cell cycle progression. Additionally, flies expressing MLL-AF9 display impairment in higher order chromatin integrity, evidenced in decondensation of mitotic figures. The effects of MLL fusion proteins in Drosophila suggest that alteration of chromatin structure by MLL fusion proteins may contribute to the lethal phenotype. Our results indicate that the mode(s) of action of MLL-AF9 in Drosophila varies from that of MLL-AF4. Taken together, the expression of MLL fusion proteins in Drosophila provides a new and powerful system to reveal and characterize biological activities associated with MLL fusion proteins.
Introduction
Rearrangements of the Mixed Lineage Leukemia (MLL) gene (also termed ALL-1, HRX, or HTRX), positioned at chromosome band 11q23, occur in 5-10% of patients with acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML). Two groups of patients with acute leukemia who show high concordance (60-90%) with 11q23 chromosome translocations are children under the age of 12 months and children or adults with therapy-related leukemia. Neoplasms with MLL rearrangements are clinically aggressive and respond poorly to therapy. The prevalence of these leukemias in infants, sometimes only several weeks old (in at least some, but probably in most of these cases, the chromosome translocations already occur in utero), and the rapid appearance of the therapy-related neoplasms suggested that few, if any, additional mutations are necessary to produce the malignant phenotype (reviewed in Canaani et al., 1995; Ayton and Cleary, 2001) .
Currently, more than 50 different chromosome translocations have been associated with 11q23, pointing MLL as unusually promiscuous in recombination with partner genes. All chromosome translocations result in gene fusions and consequent production of chimeric proteins. The latter are composed of the Nterminal 1300-1400 residues of MLL, linked in phase to the polypeptides encoded by the segment of the partner gene translocated to chromosome 11 (Gu et al., 1992; Tkachuk et al., 1992) . The N-terminal 1300-1400 residues of MLL contain two motifs shared with Trithorax (TRX), the Drosophila homologue of MLL, and two, which are not. The formers are two short polypeptides, SNL1 and 2, conferring nuclear speckle pattern to the MLL protein (Yano et al., 1997) . The latter are AT hooks, which bind the minor groove of AT-rich DNA, and a cysteine-rich region with homology to mammalian DNA methyl transferase (MT) (Ma et al., 1993) and to methyl binding domain protein 1 (MBD1) (Hendrich and Bird, 1998) . The last region (MT) of MLL overlaps with a transcriptional repression domain (Zeleznik-Le et al., 1994; Prasad et al., 1995) and binds to genomic DNA (Slany et al., 1998) . The other two highly conserved domains shared by MLL and TRX, the Su(var)3-9, enhancer-of-zeste, trithorax (SET) domain and the plant homeodomain (PHD) zincfingers that mediate protein-protein interaction (Fair et al., 2001) , are absent from the chimeric proteins. Both MLL and its Drosophila counterpart TRX positively regulate the maintenance of Hox gene expression during development (Breen and Harte, 1993; Yu et al., 1995; van Lohuizen, 1999) . MLL was recently found to assemble a supercomplex of around 30 components mostly involved in chromatin remodelling or covalent modifications (Nakamura et al., 2002) . The SET domain of MLL was demonstrated to methylate lysine 4 of histone 3 (Milne et al., 2002; Nakamura et al., 2002) .
The mechanism(s) by which MLL fusion proteins induce leukemia is not known. A major direction taken to approach this issue has been the development of animal models (Corral et al., 1996; Ayton and Cleary, 2003; Forster et al., 2003) . We sought to exploit Drosophila as an additional potential model system to uncover mechanistic actions directly associated with MLL fusion proteins. In the present work, we expressed MLL-AF9, MLL-AF4, and normal MLL in flies. Both AF4 and AF9 (ALL1 fused gene from chromosome 4 or 9, respectively) are transcription factors that occur as one of the most common fusion partners (Isnard et al., 2000; . We show that whereas flies expressing normal MLL are completely viable, expression of MLL-AF4 and MLL-AF9 interferes with normal Drosophila development causing late larval to pupal lethality. Lethality is not manifested when MLL-AF9 or MLL-AF4 expression is restricted to early embryogenesis nor when only the truncated N-terminal portion of MLL or the fusion portions of the AF4 and AF9 proteins are expressed. We demonstrate that MLL-AF9 confers a higher rate of cell proliferation, whereas MLL-AF4 appears to delay cell cycle progression. Moreover, MLL-AF9, but not MLL-AF4, induces global decondensation of chromatin along chromosomal arms. The variance between the phenotypes observed in MLL-AF9 and MLL-AF4 transgenic animals underscores the influence that the C-terminal partners of the MLL fusion proteins have in contributing to the chimera's aberrant activities. Our work supports the use of Drosophila as a valid model system for studies directed at dissecting the molecular functions of MLL fusion proteins.
Results

MLL fusion proteins induce larval to pupal lethality in Drosophila
We set out to express in Drosophila the normal and two mutated forms of MLL and to analyse their biological and molecular consequences on fly development. The two most prevalent MLL chimeric proteins, MLL-AF4 and MLL-AF9, were selected. The C-terminal portions of the chimeric proteins, replacing the PHD fingers and the SET domain of MLL, possess transcriptional activation capacity (Prasad et al., 1995; Slany et al., 1998) . The UAS-Gal4 system of Drosophila was utilized to express the proteins (structures shown in Figure 1a ; Brand and Perrimon, 1993) . We confirmed that the transgenic lines established produced the relevant RNAs by applying RT-PCR (Figure 1b) . Using antibodies against the N-terminus of MLL (polyclonal Ab 169 directed against MLL residues 79-290), we were also able to detect the appropriate protein bands corresponding to MLL, MLL-AF9, and MLL-AF4; MLL Nterminus, AF9, and AF4 C-termini carry a C-terminal myc-tag and were detected by anti-myc mAb (Figure 1c) .
Homozygous trx b11 mutants are embryonic lethals depicting aberrant cuticular patterns, reflecting misregulated HOX gene expression, (Breen, 1999) . A substantial portion of the trx b11 mutant embryos does not form any cuticles because they die before cuticles are formed. Mutant flies transgenic for the human proteins were tested for a functional rescue. We categorized the cuticle phenotypes into three classes: malformed (entire denticle belts missing), partial rescue (all denticle belts present but transformed to that of another segment) and rescue (wild-type appearance) (Figure 1d ). Coexpression of MLL rescues the cuticular phenotype partially (9%), indicating that the human protein can to a certain degree compensate for the lack of the fly TRX protein.
However, a complete rescue was never observed (Figure 1d ), suggesting that either the expression pattern of MLL (in this case approximated by an ubiquitously maternally expressing a-tubulin GAL4 driver V2H) is not completely equivalent to trx expression or that the MLL protein itself can only partially fulfil TRX functions. A truncated form of MLL, as MLL-AF4, is not able to rescue the trx mutant phenotype showing that the complete protein is necessary to elicit the rescue of cuticular patterns.
To investigate the effects of MLL, MLL-AF9, and MLL-AF4 expression in Drosophila development, several Gal4 drivers displaying specific temporal and spatial expression patterns were utilized (Table 1 summarizes the Gal4 driver lines used). For some of the Gal4 driver lines, MLL, MLL-AF9, or MLL-AF4 was expressed only during early embryogenesis (Table 1 ). This stage was of particular interest since TRX and MLL are required to maintain appropriate HOX gene expression during embryonic development. In principle, MLL and/ or MLL-AF9 and MLL-AF4 could prevent proper maintenance of gene expression patterns by TRX during embryogenesis. However, we did not find any deleterious effect on Drosophila development in any of these transgenic lines. Other Gal4 drivers conferred protein expression from late embryogenesis and throughout development (Table 1) . T80 Gal4 depicts a constitutive promoter, which becomes active in all imaginal discs (Wilder and Perrimon, 1995) . Act5C was isolated from the actin promoter and allows expression throughout development, peaking at late larval and pupal stages (Ito et al., 1997) . Daughterless is a maternal protein ubiquitously expressed throughout development (Cronmiller and Cummings, 1993; Wodarz et al., 1995) . Expression of MLL-AF9 and of MLL-AF4, but not of MLL, under the control of these three drivers resulted in lethality. Manifestation of lethality correlated with the presence of proliferating tissues, which in Drosophila occur primarily in imaginal discs at larval stage. These results, in conjunction with those involving early expressing lines, suggest that MLL-AF9 and MLL-AF4 interfere with functions operating during late stages of Drosophila development.
Finally, we examined the effect(s) MLL-AF9 and MLL-AF4 may have on fly development when expressed at the hematopoietic system of the fly. We found that MLL-AF9 and MLL-AF4, but not MLL, induced lethality when expressed under the MZ1580 Gal4 driver (Table 1 ). The MZ1580 driver was initially isolated in an enhancer screen for Gal4 expression in glial cells (Hidalgo et al., 1995) . It was subsequently noted that this driver induces expression in macrophages (hemocytes). The latter comprise most of the Drosophila immune system. Other blood lineage-specific Gal4 drivers show lethality solely for the MLL fusion proteins. P(GawB)5015 is described in Flybase as a lymph gland-specific Gal4 driver and induces lethality of both MLL-AF9 and MLL-AF4 expressing flies. Gcm (glial cell missing) Gal4 is expressed in hemocytes (Bernardoni et al., 1997; Lebestky et al., 2000) and induces pupal lethality in MLL-AF9-expressing flies, as does Dorothy-Gal4 (Kimbrell et al., 2002) , which is expressed in the hematopoietic system. CgGal4 is expressed in circulating hemocytes, lymph gland, and fat body (Asha et al., 2003) and induces partial lethality in MLL-AF4 flies specifically. These findings underline the fact that expression of MLL fusion proteins in the hematopoietic system is sufficient for the manifestation of MLL-AF9-and MLL-AF4-associated lethality.
Importantly, several lines of evidence demonstrate that only the fusion proteins contribute to the lethal phenotype. First, it was observed that the severity of the lethal phenotype associated with MLL-AF4 and MLL-AF9 transgenic animals correlated with the expression of the selection marker white. The expression level of white reflects the extent to which the neighboring gene on the genomic DNA affects expression of the UAS construct. Thus, flies with darker red eyes produce a higher amount of transgenic protein. Indeed, flies that exhibited darker pigmented eye color, such as the lines MLL-AF9/T2 and MLL-AF4/T1G, died earlier than fly lines with lighter eyes, such as MLL-AF9/T5 and MLL-AF4/4C (Figure 2 and data not shown). Second, this dose effect is also reflected in the failure to obtain a complete lethal phenotype when crosses were performed at 181C (Table 1 ; the GAL4 system is temperature dependent, with higher expression levels at 281C). Third, to assess whether the lethality could be caused by the AF4, AF9, or by the N-terminal portion of the MLL protein, we expressed these parts singly in transgenic flies. In all cases, we could confirm an appropriate Utilization of the daughterless Gal4 driver enforced ubiquitous expression of the proteins throughout development at 281C. MLL-AF9-and MLL-AF4-expressing progeny developed slowly and displayed larval to pupal lethality. In contrast, MLL-expressing flies were healthy and normal. Shown below the graph is the number of animals that reached specific stages of Drosophila development from a starting pool of 100 embryos at 281C. Numbers represent four independent crossings Transgenic flies expressing different derivatives of MLL and fusion partners (see Figure 1a ) were crossed to several development and tissue-specific GAL4 drivers. While embryonic expression of MLL-AF9 and MLL-AF4 induced no lethal phenotype, expression of the gene throughout or during late development caused fly lethality at 281C (expression of the transgene is highest at this temperature). Expression of MLL-AF9 and MLL-AF4 in the hematopoietic system was also found to be sufficient for the manifestation of MLL-AF9-and MLL-AF4-associated lethality. Importantly, lethality was never observed for transgenic lines expressing MLL, the N-terminal portion of it or the C-terminal parts of AF4 and AF9 when using the daughterless GAL4 driver expressing ubiquitously. (À) not determined expression of the transgenes (Figures 1b and c) . However, in no case was lethality observed. Taken together, our results demonstrate that only the fusion proteins contribute to the lethal phenotype, validating the specificity of this Drosophila transgenic system.
MLL-AF9 and MLL-AF4 interfere with cell cycle progression as do late lethal trx mutants
We were intrigued by our finding that MLL-AF9 and MLL-AF4 induced lethality at larval stages in Drosophila development when expressed in the blood system.
We speculated that MLL-AF9 and MLL-AF4 inhibited directly the proper development of the immune system. However, we failed to find major abnormalities in number and in morphology of blood cells and lymph glands (data not shown). This result is consistent with studies of mice harboring the MLL-AF9 transgene, which develop leukemia with a latency of 4-12 months, suggesting that additional mutations are required for the development of the disease (Corral et al., 1996; Ayton and Cleary, 2001 ). The lethality induced by MLL chimeric proteins might preclude the emergence of such secondary hits. It is also conceivable that aside from their role in immunity, the developmental function of hemocytes to secrete extracellular matrix components essential for morphogenesis (Murray et al., 1995) is disturbed that leads to the late larval/early pupal lethality.
Having observed that MLL fusion proteins induce fly lethality when expressed in proliferating tissues (imaginal discs) late in development (Table 1) , we considered the possibility that MLL fusion proteins have a more global effect on cell viability by impairing cell division. If so, we would expect an abnormal progression of cell division leading to late lethality. In this context, we noted that an extensive study of several trx mutant alleles had previously documented similarities in phenotypes among certain trx alleles and signal transduction mutants impairing cell division (Breen, 1999) . Indeed, based on these observations, it was suggested that the TRX protein is able to incorporate into several complexes whose functions are required at different times in development (Breen, 1999) . Lethality associated with homozygous trx mutants ranged in its severity depending on the allele, regardless of the TRX maternal contribution. We selected two mutants, the JY16 and the E3 alleles, which are lethal at the stages observed when MLL fusion proteins are expressed. We asked whether these two mutant alleles, showing late larval or pupal lethality, were also associated with cell proliferation phenotypes.
To address this, we isolated brains from wild-type larvae, larvae harboring a copy of the null trx allele (trx b11 ) and a copy of the trx alleles (trx JY16 or trx E3 ), and compared them with larvae expressing MLL, MLL-AF9, and MLL-AF4 induced by daughterless Gal4. Isolated brains were incubated in vitro with BrdU for 1.5 h at 251C. Proliferating cells appeared positive when probed with a monoclonal antibody against BrdU. As shown in Figure 3 , replicating cells were confined to the two lobes of the hemisphere and to the mid-brain (Figure 3 , wild type). Both trx mutants displayed a clear reduced level of replicating cells as compared to wild type. This finding correlates well with the reduced size of brains from larval or pupal trx mutants. In fact, the number of BrdU-positive cells appears virtually zero. We could not detect any significant abnormalities in cell proliferation in flies expressing MLL and MLL-AF4. However, a higher number of BrdU-positive cells was observed in MLL-AF9 transgenic flies, suggesting that cells are proliferating at a faster rate (Figure 3) .
To characterize closer the alteration in cell proliferation associated with MLL-AF9, we performed an in vivo experiment by feeding BrdU to transgenic larvae for 30 min followed by transfer of the larvae to normal food. We determined the earliest time required for mitotic chromosomes at specific stages of the cell cycle to first incorporate BrdU by detecting BrdU with a monoclonal antibody against BrdU in brain squash preparations. This time reflects the rate by which proliferating cells progress through mitosis (Figure 4) . At 0 min post-BrdU pulse, the three transgenic fly lines and wild-type exhibited BrdU-labelled chromatin at interphase/telophase. The time in labelling of interphase/telophase nuclei was in good accordance with or the trx b11 /trx E3 genotype are able to develop to larval or pupal stages, respectively. Brain squashes were performed for these rare surviving trx mutant larvae. It was observed that a lower number of cells, as detected by DAPI staining (data not shown), were present in one squashed brain as compared to wild type. Most of the cells appear to be in interphase as characterized by dense, small nuclei. The remaining nuclear spreads appear 'prophase-like', resembling an initial phase of chromosomal condensation. Around750% of trx mutant cells display this particular nuclear structure. Only one or two 'normal' metaphase chromosomes, structurally resembling wild-type metaphase mitotic figures, were detected per trx mutant brain (suggesting that in general cells do not reach metaphase). The chromosomes of surviving cells appear fluffy. (c) MLL-AF9 but not MLL or MLL-AF4 affects global chromatin structure. Metaphase spreads from MLL and from MLL-AF4-expressing larval brain cells display the same chromatin conformation as in wild type (WT). However, aberrations in chromosome structures are clearly observed in MLL-AF9 larval brains. Note the decondensation of chromatin along the arms of the mitotic figures ('Decondensed'). Such structures are highly reduced in MLL-and MLL-AF4-expressing transgenic animals and in WT. 'Fragmented' mitotic spreads were also frequently observed in MLL-AF9 transgenes. Percentages indicate the frequency by which the distinct metaphase spreads were observed in two brains at four independent experimental set-ups. Similar frequencies were observed when brains were treated with colchicine prior to squashing (all figures were captured at a Â 1000 magnification) previous published results by Loupart et al. (2000) , who reported that in wildtype, 10 min is sufficient for brain cells to incorporate ingested BrdU. The labelled diffuse chromatin in wild-type nuclei reached prophase, metaphase, and anaphase at 30, 120, and 180 min, respectively, post-BrdU pulse. MLL-AF9 transgenic animals exhibited completely labelled BrdU mitotic figures at metaphase at 60 min post-BrdU pulse and reached anaphase within 90 min. Again, these results demonstrate the ability of MLL-AF9 to expedite the cell cycle. Interestingly, at this higher resolution (compared to the in vitro labelling), we also detected a change in kinetics of cell proliferation in animals expressing MLL-AF4. In contrast to MLL-AF9, labelled chromatin (at 0 time point) of MLL-AF4-expressing cells proceeded through prophase and metaphase in a similar rate as MLL and wildtype; however, labelled mitotic figures at anaphase were first observed as late as 4 h post-BrdU pulse, suggesting that MLL-AF4 delay the later steps of mitosis. Unexpectedly, MLL accelerated cell cycle progression in a similar, yet slower, manner as MLL-AF9. Although we were surprised that MLL completes cell division slightly quicker than wild type, this enhanced proliferation has no effect on fly viability. Possibly, the effect of MLL on cell division is below a threshold required for derailment of cell integrity in Drosophila.
Taken into account the homology between TRX and MLL, our observations that expression of MLL fusion proteins and the lack of functional TRX result in cell cycle progression abnormalities and in inhibition of replicating cells, respectively, suggest a functional link between the three proteins, and raises the possibility that MLL-AF9 and MLL-AF4 may act in a dominant negative or positive fashion to modulate TRX activity in the regulation of cell proliferation. However, we cannot dismiss the possibility that MLL fusion proteins may misregulate alternative pathways leading to abnormal cell cycle progression. The C-terminal partners of the chimera proteins might determine the effect of MLL fusion proteins on progression of the cell cycle.
MLL-AF9 and late trx lethals, but not MLL-AF4 and MLL, display global chromatin condensation defects MLL as a homologue of TRX has been thought to regulate continued cell proliferation by the maintenance of correct chromatin integrity. Thus, a possible venue through which MLL-AF9 and MLL-AF4 may alter the abnormal progression of cell division is the state of chromatin integrity. We were therefore interested in assessing the status of chromatin condensation of mitotic figures in late trx lethals and in MLL, MLL-AF9, and MLL-AF4 transgenic flies. For this kind of studies the Drosophila brain has been traditionally used as the tissue of preference. Brain squashes were performed, and DAPI-stained chromatin was analysed in at least three different experimental settings.
In Figure 5a the normal Drosophila karyotype is depicted. The chromatin phenotype associated with both trx JY16 and trx E3 was characterized by global chromatin decondensation, resembling 'prophase-like' chromatin ( Figure 5b ). The remarkable absence of distinct metaphase spreads suggests that nuclei lacking trx function cannot enter or complete the cell cycle ( Figure 5 ). Similar results were obtained when trx mutant brains were incubated with colchicine in order to arrest the cell cycle at metaphase, supporting an impairment of proper chromatin condensation required for cell division (data not shown). MLL, MLL-AF9, and MLL-AF4 transgenic flies were expressed with the daughterless-Gal4 driver, and the progeny of the latter were monitored to be lethal at Figure 6 The MLL, MLL-AF9, and MLL-AF4 proteins target different sites on polytene chromosomes. TRX is detected with polyclonal antibodies (red), whereas MLL and MLL-AF9 are detected with monoclonal antibodies to FLAG (green), and MLL-AF4 with monoclonal antibodies to AF4 (green). Polytenes on panels a-c were captured at Â 400 magnification, whereas lower images at panels d-f are at Â 1000 magnification. MLL was found to bind strongly at limited sites with TRX (a, d). MLL-AF4 colocalized with TRX at fewer bands than MLL and with a weaker intensity, possibly reflecting adjacent but not identical binding of the two proteins (c, f). In contrast, MLL-AF9 (green) and TRX (red) did not show colocalization (b, e). Shown in images (d-f) are the binding profiles of MLL, MLL-AF9, and MLL-AF4 at the cytological location 2C, where TRX has been reported to bind. Staining with polyclonal antibodies against MLL (Ab 169) demonstrated that the binding profile of MLL-AF9 and MLL-AF4 differ considerably from that of MLL. As shown, MLL was found bound throughout the chromosomes (k, l). MLL-AF9 was largely concentrated at the heterochromatin-rich chromocenter (g, h, arrow-head). On the other hand, MLL-AF4's binding pattern was confined to many bands along the chromosome arms, and not to the chromocenter (i, j). The arrows in MLL-AF9 point to polytene pairing defects often observed five times more frequently than in wild-type polytene squashes, suggesting that the chromatin from MLL-AF9 transgenic animals is more labile (see Figure 5) 281C (Figure 2 ). Spreads from MLL and MLL-AF4 transgenic brains show that MLL mitotic figures are indistinguishable from those of wild-type flies (Figure 5c ). However, metaphase spreads from MLL-AF9 transgenic brains showed a striking effect on chromosome structure. Although roughly 55% of metaphase spreads appeared to be completely normal, a significant number of mitotic figures from MLL-AF9 were characterized by decondensed portions along the chromosomal arms of the mitotic figures (Figure 5c) . Interestingly, such chromosomal defects were reported in replication defective mutants (Pflumm and Botchan, 2001 ). The effect is less severe in comparison to the decondensation effect observed in late trx mutants (where mitotic figures were rarely detectable), since the vast majority of MLL-AF9 chromosomal mitotic figures resemble in structure to wild-type metaphase chromosomes. Also shown in Figure 5c , a large proportion of cells that resembled fragmented-like chromosomes. Like the decondensed chromosomal defects, fragmented mitotic figures too were observed in replication defective mutants (Loupart et al, 2000; Pflumm and Botchan, 2001) . Quantitation indicated that 30 and 14% of metaphase spreads from cells expressing MLL-AF9 were associated with decondensed and fragmented structures, respectively. Similar percentages were observed when brains were treated with colchicine prior to squashing (data not shown). Taken together, it appears that MLL-AF9-expressing flies exhibit a defect in chromatin morphology which could also be indirectly caused by the aberrant cell division rate.
MLL, MLL-AF9, and MLL-AF4 have different binding patterns on polytene chromosomes
Presently, there is no comprehensive data as to the extent of overlap between the targets of MLL and its leukemic fusion forms. The Drosophila system allows visualization of protein binding to target elements by applying immunostaining of polytene chromosomes. Comparison of the binding patterns of TRX, MLL, MLL-AF9, and MLL-AF4 might reveal how MLL overlaps with TRX in physiologically relevant complexes, and, importantly, whether MLL fusion proteins bind the same targets of the normal protein. For detection purposes, a FLAG tag was juxtaposed to the C-terminus of MLL and MLL-AF9, enabling detection of the proteins with a monoclonal antibody against FLAG. MLL-AF4 was detected with a monoclonal antibody against AF4.
A limited number of MLL bands were found to colocalize with TRX, ranging around 10% (Figure 6a,  d ). Less overlapping sites were found between TRX and MLL-AF4 (Figure 6c, f) . TRX and MLL-AF9 seem to have mutually exclusive patterns (Figure 6b, e) . Of a greater interest is the direct comparison among the binding patterns of MLL, MLL-AF9, and MLL-AF4 (Figure 6g-l) . To avoid signal variability due to different antibodies, we used an affinity-purified polyclonal antibody against the N-terminus of MLL (Ab 169) to detect the three proteins. As shown, besides some specific bands, we observed a general distribution of MLL throughout polytene chromosomes (Figure 6k, l) . On the other hand, MLL-AF9 was found only in a limited numbers of euchromatic bands, and intriguingly, mostly concentrated at heterochromatic sites at the chromocenter (Figure 6g , h arrow-head), whereas MLL-AF4 extensively bound to only euchromatic sites (Figure 6i , j). The clear difference in binding patterns of MLL-AF9 and of MLL-AF4 is consistent with our suggestion that the proteins interfere with distinct pathways to induce fly lethality.
Discussion
We report here the establishment of a Drosophila model system to study the biological and molecular consequences of the expression of MLL fusion proteins. We have shown that whereas MLL transgenic animals are completely viable, MLL-AF9 and MLL-AF4 induce late fly lethality. Although the similar and severe phenotype induced by both MLL fusion proteins suggests a common mode of action, multiple lines of evidence indicate distinct pathways. First, although MLL-AF9-and MLL-AF4-expressing cells display an abnormal rate of cell division, MLL-AF9 expedites, whereas MLL-AF4 delays, the rate of cell proliferation. Second, substantial chromatin aberrations are observed in MLL-AF9 transgenic animals. Third, MLL, MLL-AF9, and MLL-AF4 exhibit distinct binding patterns on polytene chromosomes, suggesting that the proteins target different genes. The C-terminal partners of MLL-AF9 and of MLL-AF4 might dictate the behavior of the chimera proteins. These results also demonstrate that AF4 and AF9 fusions to the MLL N-terminal part dramatically alter the binding sites, thus, presumably directly affecting new target genes or indirectly reducing the expression of normal target genes by depletion of the normal local MLL pool. Collectively, these results strongly indicate an important role for the MLL fusion partner in determining biological effects of the MLL derivatives in Drosophila. These results also underscore the potential of the Drosophila model system to uncover the different pathways affected by the fusion proteins. The situation observed in Drosophila might bear on different molecular targets hit by MLL-AF9 and MLL-AF4 in human leukemias. The former species is mainly associated with AML, while the second occurs exclusively in ALL .
Our analysis with late lethal trx mutants suggests the importance of trx-mediated chromatin integrity for cell proliferation. The striking reduction of metaphase spreads from whole trx mutant brains accounts for the lack of proliferating cells and for the retardation in growth, as evidenced in the smaller brains. In addition, the lobes where the majority of the proliferating cells reside appear to be underdeveloped, and are phenotypically identical to Drosophila DNA replication-deficient mutants (Krause et al., 2001) . The presence of an altered chromatin structure in trx JY16 and trx E3 mutants is well linked with the replication defect identified. These results suggest that trx may control genes that possess an additional and vital function associated with DNA replication and necessary at late development. This function appears distinct from its earlier maintenance role. Since TRX and MLL act at the level of chromatin, mutations in these genes could conceivably result directly in improper chromatin structures. This would lead to defects in replication either by directly influencing the DNA replication machinery, or alternatively, by affecting target gene expression, and thus, indirectly misregulating cell proliferation and/or replication. Indeed the latter scenario is plausible since several HOX genes, such as HOXA7, HOXA9, and HOXA10, are direct targets of MLL and their expression is associated with MLL fusion proteins (Hanson et al., 1999; Rozovskaia et al., 2001; Ayton and Cleary, 2003) . Future studies should uncover whether the observed aberrant chromatin patterns are the cause of the proliferation defects or rather a consequence of the misregulated cell cycle by the fusion proteins. If our observed MLL fusion protein-altered chromatin and aberrant cell proliferation occur in mammalian blood precursors, it might facilitate accumulation of secondary mutations leading to leukemia. Further experiments utilizing the Drosophila system should elucidate the different molecular functions associated with distinct MLL fusion proteins.
Materials and methods
DNA constructs
The full-length MLL cDNA was cloned into the EcoRI site of the pUAST vector (Brand and Perrimon, 1993) . The MLL-AF9 construct consists of the first 4086 nucleotides of MLL cDNA juxtaposed to nucleotides 1432-1704 of AF9 cDNA. The MLL-AF9 fusion construct was cloned into the EcoRI site of pUAST. Both MLL and MLL-AF9 constructs contain a FLAG epitope (GAC TAC AAG GAC GAC GAT GAC AAG) linked in frame to the C-termini.
The N-terminal MLL fragment is encoded by the first MLL 4086 nucleotides and contains a C-terminal myc-tag (GAG CAG AAG CTG ATC TCC GAG GAG GAT CTG). The AF4 and AF9 fusion fragments consist of the last 2589 and 270 nucleotides of the ORFs, respectively, and are linked to a Cterminal sequence encoding myc-tag.
Fly culture and phenotypic analyses
Strains Oregon R as wild-type control and the transformation host white (w 1118 ) were raised on standard fly food at 181C or 251C with 60-70% relative humidity. At least five different independent transformants were kept as stocks, and two lines were selected for experiments. Virgins from transgenic lines were crossed to several Gal4 driver strains' males. Crosses were kept at 18, 25, or 281C. Progenies were then scored for the lethal phenotype.
The following Gal4 drivers were obtained from the Bloomington Stock Center unless noted in parenthesis: Act5c Gal4/CyO, armadillo Gal4/CyO; en2.4Gal4/SM5, Cy; CgGal4 (J Bogin, ZMBH, Heidelberg, Germany), Gcm-Gal4/CyO, daughterless-Gal4 (J Dura, CNRS, Montpellier, France); Dorothy-Gal4, MZ1580 (A Brand, Wellcome/CRC Institute, Cambridge, UK), P(GawB)5015, T80 Gal4/CyO, V2H. The trx
JY16
, trx
E3
, and trx B11 mutants (Breen, 1999) were obtained from TR Breen (Southern Illinois University).
Analyses of mitotic chromosomes and of BrdU experiments were performed according to Loupart et al. (2000) and Pflumm and Botchan (2001) .
